ArticleNature communications2026
Reprogramming energy system for growth and bioproduction from CO₂ and methanol in Escherichia coli.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microbial CO₂ assimilation provides a strategy for sustainable biomanufacturing. However, CO₂ reduction requires substantial energy input, while native energy systems are tightly regulated and extensively consumed by endogenous metabolism, limiting assimilation efficiency. Here, we design and construct an orthogonal energy system in Escherichia coli, achieving an intracellular NUDH concentration exceeding 7.0 mM and an NUDH/NUD⁺ ratio above 55. Subsequently, we design a CO₂-formate-acetyl-CoA-pyruvate-malate pathway and reprogram key enzymes for NUDH-dependent operation. Integration of the OES-driven CAM* pathway with a rationally rewired native electron transport chain supports growth of the engineered E. coli on CO₂ and methanol, with a doubling time of 8.6 ± 0.3 h and a maximum OD₆₀₀ of 37.5 ± 5.8. Moreover, the platform extends CO₂ assimilation to biosynthesis of multiple chemicals from distinct CAM* pathway nodes, including mevalonate, lactate, 2,3-butanediol, and succinate. Together, these results establish a framework for reprogramming microbial energy metabolism and expanding one-carbon biotransformation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.